Intravesical Gene Therapy: In Vivo Gene Transfer Using Recombinant Vaccinia Virus Vectors

Sharon S. Lee, Laurence C. Eisenlohr, Peter A. McCue, Michael J. Mastrangelo, Edmund C. Lattime

Research output: Contribution to journalArticlepeer-review

67 Scopus citations

Abstract

Intratumoral gene transfer may be a significant tool in active immunotherapy. The ability to insert functional genes into a tumor in vitro and in vivo using recombinant vaccinia vectors was examined in the murine bladder tumor model. Vaccinia recombinants expressing the influenza hemagglutinin or nucleoprotein antigens infected/transfected murine (MB-49 and MBT-2) and human (T24) bladder tumor cell lines in vitro. Systemic vaccinia immunity was induced with as few as 10 plaque-forming units of recombinant vaccinia instilled intravesically, and the encoded protein was expressed in vivo in tumor and urothelium. However, preim-munity to vaccinia did not inhibit intravesical tumor transfection. Thus, recombinant vaccinia virus is effective in introducing foreign antigens locally into tumor in vivo, supporting its use in clinical immunotherapy.

Original languageEnglish
Pages (from-to)3325-3328
Number of pages4
JournalCancer Research
Volume54
Issue number13
StatePublished - Jul 1 1994

Keywords

  • Animals
  • Carcinoma, Transitional Cell/genetics
  • Female
  • Genetic Vectors/genetics
  • Mice
  • Mice, Inbred C57BL
  • Spleen/immunology
  • T-Lymphocytes, Cytotoxic/immunology
  • Transfection/methods
  • Tumor Cells, Cultured
  • Urinary Bladder Neoplasms/genetics
  • Urinary Bladder/microbiology
  • Vaccinia virus/genetics

Fingerprint

Dive into the research topics of 'Intravesical Gene Therapy: In Vivo Gene Transfer Using Recombinant Vaccinia Virus Vectors'. Together they form a unique fingerprint.

Cite this